Common GLP-1 Side Effects Made Simple
Drugs like Ozempic, Wegovy, Zepbound, and Mounjaro have changed the way doctors manage type 2 diabetes and obesity. These medications, called GLP-1 receptor agonists, help the body produce more insulin after meals, slow down digestion, and reduce appetite. The results can be dramatic, including weight loss, improved blood sugar control, and a reduced risk of heart disease. But there’s […]
Zepbound and the Future of Weight Loss
Most people are familiar with the bundle of medications that have hit our shelves over the past five or so years, which have either directly or indirectly revolutionized the whole field of weight loss. We can now introduce the latest, and in many ways the most exciting product in this field, which is Zepbound. In […]
Wegovy is Being Tested to Treat Severe Fatty Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NASH), affects nearly one-third of the US population (over 100 million people). Obesity is thought to be the most common cause. In some cases, MASLD can develop into a more serious condition called metabolic dysfunction-associated steatohepatitis (MASH). Both conditions develop when the liver […]
The Link Between Sleep and Healthy Weight
Is this you? It’s late at night, and suddenly a bowl of pasta sounds like the perfect idea. Or maybe you wake up for a quick bathroom trip and find yourself craving a midnight snack. Is it normal? No, but it is surprisingly common, and the mismanagement of sleep and nutrition could affect not just […]
Ozempic, Chronic Kidney Disease, and Diabetes
In January 2025, the FDA approved Ozempic (semaglutide) to help treat patients with chronic kidney disease and diabetes. Semaglutide belongs to a group of drugs called glucagon-like peptide-1 receptor agonists (GLP1-RAs), which were originally approved to help control blood sugar in people with type 2 diabetes. Other forms of GLP1-RAs include Mounjaro, Wegovy, semaglutide, and […]
New Hope for Lowering the Risk of Dementia
Just this week, I was asked by a colleague to comment on a fairly technical article, and I was struck by the exact wording used in its opening question: Are cardioprotective glucose-lowering agents associated with reduced risk of dementia? I spend a fair bit of time reviewing and replying to questions and requests from our […]
A Pharmacist’s Guide to Ozempic and Weight Management
Ozempic (semaglutide) has become one of the most talked-about drugs in recent memory, not just in endocrinology circles, but across dinner tables, in TikTok feeds, and celebrity interviews. What started as a diabetes treatment has transformed into a pop culture phenomenon, thanks to its effectiveness in weight management. But as demand has skyrocketed, so have […]
Sticking With GLP-1 Helps to Maintain Weight Loss
Anyone who has struggled to maintain weight loss knows the frustration of losing weight only for it to pile right back on once we slow down or stop whatever weight loss program or diet we were following. This yo-yo effect can discourage, demoralize, and even damage our health. Yet, many diet and exercise programs are […]
The Truth: Diet and Exercise Vs. Obesity Medication
If there’s still some doubt in your mind about whether you can lose more weight with a simple diet and exercise program than you can with the highly popular new weight-loss medicines, then you should pay some attention to the following quote that puts this issue to rest once and for all. According to Dr. […]
Introducing Pulmonary Rehab
Last week, I was hit with that dreaded seasonal flu that has been making the rounds in the northern hemisphere. While most of those nearest and dearest to me recovered after just a few days of bed rest, mine decided to go straight to my lungs, leaving me breathless…and with a severe case of pneumonia. […]
